The Pennsylvania State University
暂无分享,去创建一个
[1] Philip S. Yu,et al. Transfer Feature Learning with Joint Distribution Adaptation , 2013, 2013 IEEE International Conference on Computer Vision.
[2] Seung Ja Oh,et al. Phosphoinositide specificity determines which cytohesins regulate &bgr;1 integrin recycling , 2012, Journal of Cell Science.
[3] Sven Diederichs,et al. The hallmarks of cancer , 2012, RNA biology.
[4] S. Vrieze. Model selection and psychological theory: a discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC). , 2012, Psychological methods.
[5] L. Santy,et al. CNK3 and IPCEF1 produce a single protein that is required for HGF dependent Arf6 activation and migration. , 2012, Experimental cell research.
[6] Qiang Yang,et al. Heterogeneous Transfer Learning for Image Classification , 2011, AAAI.
[7] Pengxiang Li,et al. HIT Implementation in Critical Access Hospitals: Extent of Implementation and Business Strategies Supporting IT Use , 2011, Journal of Medical Systems.
[8] Jung lim Kim,et al. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression. , 2011, Experimental cell research.
[9] Yoshua Bengio,et al. Deep Learning of Representations for Unsupervised and Transfer Learning , 2011, ICML Unsupervised and Transfer Learning.
[10] Charity L. Washam,et al. Bone metastasis: mechanisms and therapeutic opportunities , 2011, Nature Reviews Endocrinology.
[11] Y. Lai,et al. Anticancer effects of garlic and garlic-derived compounds for breast cancer control. , 2011, Anti-cancer agents in medicinal chemistry.
[12] Yu-Chi Chen,et al. Breast cancer metastasis to the bone: mechanisms of bone loss , 2010, Breast Cancer Research.
[13] Yutaka Kodama,et al. An improved bimolecular fluorescence complementation assay with a high signal-to-noise ratio. , 2010, BioTechniques.
[14] T. Guise. Examining the metastatic niche: targeting the microenvironment. , 2010, Seminars in oncology.
[15] M. Chovanec,et al. Selenium: a double-edged sword for defense and offence in cancer , 2010, Archives of Toxicology.
[16] Rong Jin,et al. Understanding bag-of-words model: a statistical framework , 2010, Int. J. Mach. Learn. Cybern..
[17] T. Veenstra,et al. The CNK1 scaffold binds cytohesins and promotes insulin pathway signaling. , 2010, Genes & development.
[18] James W. Clancy,et al. Unregulated ARF6 Activation in Epithelial Cysts Generates Hyperactive Signaling Endosomes and Disrupts Morphogenesis , 2010, Molecular biology of the cell.
[19] C. Davis,et al. Deficiency in the 15-kDa Selenoprotein Inhibits Tumorigenicity and Metastasis of Colon Cancer Cells , 2010, Cancer Prevention Research.
[20] Seung Ja Oh,et al. Differential Effects of Cytohesins 2 and 3 on β1 Integrin Recycling* , 2010, The Journal of Biological Chemistry.
[21] David T. White,et al. GRASP and IPCEF Promote ARF-to-Rac Signaling and Cell Migration by Coordinating the Association of ARNO/cytohesin 2 with Dock180 , 2010, Molecular biology of the cell.
[22] W. Cheng,et al. Selenium Compounds Activate Early Barriers of Tumorigenesis* , 2010, The Journal of Biological Chemistry.
[23] G. Park,et al. Selenium Inhibits Metastasis of Murine Melanoma Cells through the Induction of Cell Cycle Arrest and Cell Death , 2009, Immune network.
[24] B. Rowan,et al. Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis , 2009, Breast Cancer Research and Treatment.
[25] Gaudenz Danuser,et al. Coordination of Rho GTPase activities during cell protrusion , 2009, Nature.
[26] K. S. Prabhu,et al. Gambogic acid covalently modifies IkappaB kinase-beta subunit to mediate suppression of lipopolysaccharide-induced activation of NF-kappaB in macrophages. , 2009, The Biochemical journal.
[27] James W. Clancy,et al. ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo. , 2009, Cancer research.
[28] Mark L. Diana,et al. Exploring information systems outsourcing in U.S. hospital-based health care delivery systems , 2009, Health care management science.
[29] J. Crowley,et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2009, JAMA.
[30] A. Kristal. Are Clinical Trials the “Gold Standard” for Cancer Prevention Research? , 2008, Cancer Epidemiology Biomarkers & Prevention.
[31] Sandeep Purao,et al. Case Report: Developing IT Infrastructure for Rural Hospitals: A Case Study of Benefits and Challenges of Hospital-to-Hospital Partnerships , 2008, J. Am. Medical Informatics Assoc..
[32] J. Norman,et al. Endocytic transport of integrins during cell migration and invasion. , 2008, Trends in cell biology.
[33] G. Combs,et al. Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. , 2008, Carcinogenesis.
[34] Song Tan,et al. Recombinant Protein Complex Expression in E. coli , 2008, Current protocols in protein science.
[35] J. Chirgwin,et al. Molecular biology of bone metastasis. , 2008, Molecular cancer therapeutics.
[36] James A. Bahensky,et al. Health care information technology in rural America: electronic medical record adoption status in meeting the national agenda. , 2008, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.
[37] David M. Conrad,et al. Differential involvement of reactive oxygen species in apoptosis caused by the inhibition of protein phosphatase 2A in Jurkat and CCRF-CEM human T-leukemia cells. , 2007, Experimental and molecular pathology.
[38] Adam Langley,et al. The Use of Information Technologies Among Rural and Urban Physicians in Florida , 2007, Journal of Medical Systems.
[39] T. A. Lister,et al. Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species. , 2007, Cancer research.
[40] J. Aguirre-Ghiso,et al. Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.
[41] J. Casanova. Regulation of Arf Activation: the Sec7 Family of Guanine Nucleotide Exchange Factors , 2007, Traffic.
[42] S. Munro,et al. The small G proteins of the Arf family and their regulators. , 2007, Annual review of cell and developmental biology.
[43] M. Manjili,et al. Tumor immunoediting and immunosculpting pathways to cancer progression. , 2007, Seminars in cancer biology.
[44] W. Kolanus. Guanine nucleotide exchange factors of the cytohesin family and their roles in signal transduction , 2007, Immunological reviews.
[45] Ashley A. Bush,et al. A Comparison of Transaction Cost, Agency, and Knowledge-Based Predictors of IT Outsourcing Decisions: A U.S.-Japan Cross-Cultural Field Study , 2007, J. Manag. Inf. Syst..
[46] D. Lee,et al. Immune response to firefly luciferase as a naked DNA , 2007, Cancer biology & therapy.
[47] Kum Kum Khanna,et al. From selenium to selenoproteins: synthesis, identity, and their role in human health. , 2007, Antioxidants & redox signaling.
[48] M. Therrien,et al. KSR and CNK: two scaffolds regulating RAS-mediated RAF activation , 2007, Oncogene.
[49] Cheng Jiang,et al. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells , 2007, International journal of cancer.
[50] H. Rikiishi. Apoptotic cellular events for selenium compounds involved in cancer prevention , 2007, Journal of bioenergetics and biomembranes.
[51] S. Katiyar,et al. Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling. , 2007, Free radical biology & medicine.
[52] H. Katoh,et al. Dock4 is regulated by RhoG and promotes Rac-dependent cell migration. , 2006, Experimental cell research.
[53] Mirou Jaana,et al. Clinical Information System Availability and Use in Urban and Rural Hospitals , 2006, Journal of Medical Systems.
[54] A. Chung,et al. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation. , 2006, Carcinogenesis.
[55] J. Shabanowitz,et al. RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration , 2006, The Journal of cell biology.
[56] Kazuo T. Suzuki,et al. Metabolic transformation of methylseleninic acid through key selenium intermediate selenide. , 2006, Toxicology and applied pharmacology.
[57] D. Galson,et al. Monocyte chemotactic protein‐1 (MCP‐1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion , 2006, The Prostate.
[58] Gerhard Christofori,et al. Mouse models of breast cancer metastasis , 2006, Breast Cancer Research.
[59] U. Lerner. Inflammation-induced Bone Remodeling in Periodontal Disease and the Influence of Post-menopausal Osteoporosis , 2006, Journal of dental research.
[60] A. Lucci,et al. Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer. , 2006, The Journal of surgical research.
[61] Hanna M. Wallach. Topic modeling: beyond bag-of-words , 2006, ICML.
[62] David J. Miller,et al. Unsupervised learning of parsimonious mixtures on large spaces with integrated feature and component selection , 2006, IEEE Transactions on Signal Processing.
[63] J. Kappes,et al. Kinetics of Metastatic Breast Cancer Cell Trafficking in Bone , 2006, Clinical Cancer Research.
[64] Mary E. Choi,et al. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. , 2006, Cancer research.
[65] J. Thiery,et al. Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.
[66] J. Chirgwin,et al. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. , 2005, Cancer research.
[67] W. Kolch. Coordinating ERK/MAPK signalling through scaffolds and inhibitors , 2005, Nature Reviews Molecular Cell Biology.
[68] K. Ravichandran,et al. The DOCK180/Elmo Complex Couples ARNO-Mediated Arf6 Activation to the Downstream Activation of Rac1 , 2005, Current Biology.
[69] D. Gans,et al. Medical groups' adoption of electronic health records and information systems. , 2005, Health affairs.
[70] R. Eils,et al. Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. , 2005, Cancer cell.
[71] Cheng Jiang,et al. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells. , 2005, Carcinogenesis.
[72] J. Donaldson,et al. Localization and function of Arf family GTPases. , 2005, Biochemical Society transactions.
[73] D. Yamazaki,et al. Regulation of cancer cell motility through actin reorganization , 2005, Cancer science.
[74] E. Hay,et al. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.
[75] K. Moelling,et al. CNK1 Is a Scaffold Protein That Regulates Src-mediated Raf-1 Activation* , 2005, Journal of Biological Chemistry.
[76] Song Tan,et al. The pST44 polycistronic expression system for producing protein complexes in Escherichia coli. , 2005, Protein expression and purification.
[77] L. Cantley,et al. Signals Which Build a Tubule , 2005, Nephron Experimental Nephrology.
[78] M. Hengartner,et al. A Steric-Inhibition Model for Regulation of Nucleotide Exchange via the Dock180 Family of GEFs , 2005, Current Biology.
[79] C. Der,et al. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors , 2005, Nature Reviews Molecular Cell Biology.
[80] C. D’Souza-Schorey,et al. Lysosomal Targeting of E-Cadherin: a Unique Mechanism for the Down-Regulation of Cell-Cell Adhesion during Epithelial to Mesenchymal Transitions , 2005, Molecular and Cellular Biology.
[81] P. Keely,et al. R-Ras controls membrane protrusion and cell migration through the spatial regulation of Rac and Rho. , 2004, Molecular biology of the cell.
[82] E. van Marck,et al. Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival , 2004, Clinical Cancer Research.
[83] J. Saint-Jeannet,et al. Induction of the neural crest and the opportunities of life on the edge. , 2004, Developmental biology.
[84] P. Heinrich,et al. Inhibition of gp130 Signaling in Breast Cancer Blocks Constitutive Activation of Stat3 and Inhibits in Vivo Malignancy , 2004, Cancer Research.
[85] K. Hunter,et al. Modeling metastasis in vivo. , 2004, Carcinogenesis.
[86] Lyn Patrick,et al. Selenium biochemistry and cancer: a review of the literature. , 2004, Alternative medicine review : a journal of clinical therapeutic.
[87] Suzanne Rivard,et al. A transaction cost model of IT outsourcing , 2004, Inf. Manag..
[88] N. Koide,et al. Significance of Macrophage Chemoattractant Protein-1 Expression and Macrophage Infiltration in Squamous Cell Carcinoma of the Esophagusa , 2004, American Journal of Gastroenterology.
[89] F. Kittrell,et al. Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine , 2004, Breast Cancer Research.
[90] I. Akan,et al. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. , 2004, Cytokine.
[91] A. Sancar,et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.
[92] Y. Onodera,et al. Requirement for Arf6 in breast cancer invasive activities. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[93] Amanda Spink,et al. Healthcare information systems outsourcing , 2004, Int. J. Inf. Manag..
[94] M. White,et al. CNK2 Couples NGF Signal Propagation to Multiple Regulatory Cascades Driving Cell Differentiation , 2004, Current Biology.
[95] R. Tucker. Neural crest cells: a model for invasive behavior. , 2004, The international journal of biochemistry & cell biology.
[96] D. Welch,et al. Breast cancer cells induce osteoblast apoptosis: A possible contributor to bone degradation , 2004, Journal of cellular biochemistry.
[97] T. Hla,et al. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[98] G. Borisy,et al. Cell Migration: Integrating Signals from Front to Back , 2003, Science.
[99] W. Birchmeier,et al. Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.
[100] L. Mei,et al. Human homologue of Drosophila CNK interacts with Ras effector proteins Raf and Rlf 1 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[101] K. Venkateswarlu. Interaction Protein for Cytohesin Exchange Factors 1 (IPCEF1) Binds Cytohesin 2 and Modifies Its Activity* , 2003, Journal of Biological Chemistry.
[102] J. Donaldson. Multiple Roles for Arf6: Sorting, Structuring, and Signaling at the Plasma Membrane* , 2003, Journal of Biological Chemistry.
[103] M. Roth,et al. ARNO and ARF6 regulate axonal elongation and branching through downstream activation of phosphatidylinositol 4-phosphate 5-kinase alpha. , 2003, Molecular biology of the cell.
[104] B. Shalmon,et al. Progression of mouse mammary tumors: MCP‐1‐TNFα cross‐regulatory pathway and clonal expression of promalignancy and antimalignancy factors , 2003, International journal of cancer.
[105] L. Suva,et al. Breast cancer metastasis to bone: it is not all about PTHrP. , 2003, Clinical orthopaedics and related research.
[106] M. Therrien,et al. Bimodal regulation of RAF by CNK in Drosophila , 2003, The EMBO journal.
[107] J. Matthews,et al. Mucosal repair in the gastrointestinal tract , 2003, Critical care medicine.
[108] J. Crispino,et al. Effect of the Combination of Docetaxel, Zoledronic Acid, and a COX-2 Inhibitor on the Growth of Human Breast Cancer Cell Lines , 2003, American journal of clinical oncology.
[109] L. Suva,et al. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. , 2003, Bone.
[110] M. Dowsett,et al. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[111] W. Weichert,et al. Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma , 2003, Cancer.
[112] C. D’Souza-Schorey,et al. Modulation of Rac1 and ARF6 Activation during Epithelial Cell Scattering* , 2003, The Journal of Biological Chemistry.
[113] P. Friedl,et al. Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.
[114] S. Nakanishi,et al. Tamalin Is a Scaffold Protein That Interacts with Multiple Neuronal Proteins in Distinct Modes of Protein-Protein Association* , 2003, The Journal of Biological Chemistry.
[115] E. van Marck,et al. Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer , 2003, International journal of cancer.
[116] G. Rodan. The development and function of the skeleton and bone metastases , 2003, Cancer.
[117] M. Kastan,et al. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.
[118] C. Miyaura,et al. Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis. , 2003, Biochemical and biophysical research communications.
[119] L. Suva,et al. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. , 2002, Cancer research.
[120] K. S. Prabhu,et al. Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-kappaB in up-regulation. , 2002, The Biochemical journal.
[121] Mark L. Diana,et al. Exploring Hospitals' Adoption of Information Technology , 2002, Journal of Medical Systems.
[122] A. Hall,et al. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. , 2002, Genes & development.
[123] B. Turnbull,et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[124] J. Casanova,et al. Regulation of dendritic development by the ARF exchange factor ARNO , 2002, Nature Neuroscience.
[125] T. Glant,et al. Titanium particles induce the immediate early stress responsive chemokines IL‐8 and MCP‐1 in osteoblasts , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[126] L. Trusolino,et al. Scatter-factor and semaphorin receptors: cell signalling for invasive growth , 2002, Nature Reviews Cancer.
[127] S. Nakanishi,et al. Tamalin, a PDZ Domain-Containing Protein, Links a Protein Complex Formation of Group 1 Metabotropic Glutamate Receptors and the Guanine Nucleotide Exchange Factor Cytohesins , 2002, The Journal of Neuroscience.
[128] J. Isola,et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. , 2002, Cancer research.
[129] J. Casanova,et al. Expression and analysis of ARNO and ARNO mutants and their effects on ADP-ribosylation factor (ARF)-mediated actin cytoskeletal rearrangements. , 2001, Methods in enzymology.
[130] C. Turner,et al. Cell motility: ARNOand ARF6 at the cutting edge , 2001, Current Biology.
[131] John G. Collard,et al. An essential role for ARF6‐regulated membrane traffic in adherens junction turnover and epithelial cell migration , 2001, The EMBO journal.
[132] Qingyuan Yang,et al. Increased cyclooxygenase‐2 (cox‐2) expression and activity in a murine model of metastatic breast cancer , 2001, International journal of cancer.
[133] P. Lala,et al. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis , 2001, International journal of cancer.
[134] J. Casanova,et al. Activation of ARF6 by ARNO stimulates epithelial cell migration through downstream activation of both Rac1 and phospholipase D , 2001, The Journal of cell biology.
[135] J. Pasteels,et al. Selenium Deficiency‐Induced Growth Retardation Is Associated with an Impaired Bone Metabolism and Osteopenia , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[136] T. Hla,et al. Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice* , 2001, The Journal of Biological Chemistry.
[137] J. Milner,et al. Molecular Targets for Selenium in Cancer Prevention , 2001, Nutrition and cancer.
[138] Cheng Jiang,et al. Monomethyl selenium–specific inhibition of MMP‐2 and VEGF expression: Implications for angiogenic switch regulation , 2000, Molecular carcinogenesis.
[139] C. L. Jackson,et al. Regulators and effectors of the ARF GTPases. , 2000, Current opinion in cell biology.
[140] M. Varney,et al. IL-8 expression in malignant melanoma: implications in growth and metastasis. , 2000, Histology and histopathology.
[141] Paul J. Williams,et al. Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma , 2000, Cancer.
[142] M. Dawson,et al. Interaction of GRASP, a Protein encoded by a Novel Retinoic Acid-induced Gene, with Members of the Cytohesin Family of Guanine Nucleotide Exchange Factors* , 2000, The Journal of Biological Chemistry.
[143] H. Ganther,et al. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. , 2000, Cancer research.
[144] C. L. Jackson,et al. Turning on ARF: the Sec7 family of guanine-nucleotide-exchange factors. , 2000, Trends in cell biology.
[145] C. Xian,et al. Increased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositis , 2000, British Journal of Cancer.
[146] G. Heinze,et al. Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients , 1999, British Journal of Cancer.
[147] Guo‐Jun Zhang,et al. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. , 1999, Anticancer research.
[148] D J Ferguson,et al. Dormancy of mammary carcinoma after mastectomy. , 1999, Journal of the National Cancer Institute.
[149] J. Casanova,et al. Remodeling of the actin cytoskeleton is coordinately regulated by protein kinase C and the ADP-ribosylation factor nucleotide exchange factor ARNO. , 1998, Molecular biology of the cell.
[150] J. Tavaré,et al. Nerve growth factor- and epidermal growth factor-stimulated translocation of the ADP-ribosylation factor-exchange factor GRP1 to the plasma membrane of PC12 cells requires activation of phosphatidylinositol 3-kinase and the GRP1 pleckstrin homology domain. , 1998, The Biochemical journal.
[151] L. Chaudhary,et al. Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. , 1998, Endocrinology.
[152] H. Radhakrishna,et al. Localization of endogenous ARF6 to sites of cortical actin rearrangement and involvement of ARF6 in cell spreading. , 1998, Journal of cell science.
[153] T. Guise,et al. Cancer and bone. , 1998, Endocrine reviews.
[154] H. Radhakrishna,et al. ADP-Ribosylation Factor 6 Regulates a Novel Plasma Membrane Recycling Pathway , 1997, The Journal of cell biology.
[155] R. Sunde,et al. Selenium regulation of classical glutathione peroxidase expression requires the 3' untranslated region in Chinese hamster ovary cells. , 1997, The Journal of nutrition.
[156] Bruce W. Turnbull,et al. Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .
[157] R. Klausner,et al. Aluminum fluoride stimulates surface protrusions in cells overexpressing the ARF6 GTPase , 1996, The Journal of cell biology.
[158] H. Raghav Rao,et al. A two-level investigation of information systems outsourcing , 1996, CACM.
[159] M. Burdick,et al. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.
[160] B. Gumbiner,et al. Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.
[161] D. Lauffenburger,et al. Cell Migration: A Physically Integrated Molecular Process , 1996, Cell.
[162] H. Tsukahara,et al. Selenium status and skeletal tissue metabolism in young infants , 1996, European Journal of Pediatrics.
[163] S. Manolagas,et al. Role of cytokines in bone resorption. , 1995, Bone.
[164] P. Comoglio,et al. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells , 1995, Molecular and cellular biology.
[165] R. Goldbohm,et al. Toenail selenium levels and the risk of breast cancer. , 1994, American journal of epidemiology.
[166] T. Yoneda,et al. Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma. , 1993, Cancer research.
[167] Anne J. Ridley,et al. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling , 1992, Cell.
[168] Anne J. Ridley,et al. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors , 1992, Cell.
[169] D. Männel,et al. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.
[170] F. Miller,et al. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.
[171] L. Orci,et al. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor , 1991, Cell.
[172] M. Jourdan,et al. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. , 1991, Blood.
[173] G. Mundy,et al. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. , 1991, Endocrinology.
[174] F. Sturmans,et al. Selenium in diet, blood, and toenails in relation to breast cancer: a case-control study. , 1990, American journal of epidemiology.
[175] T. Suda,et al. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. , 1990, Journal of immunology.
[176] G. Schrauzer,et al. Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. , 1985, Japanese journal of cancer research : Gann.
[177] C. Cooper,et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line , 1984, Nature.
[178] Y. Amagai,et al. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria , 1983, The Journal of cell biology.
[179] M. Olivé,et al. Breast tumor cell lines from pleural effusions. , 1974, Journal of the National Cancer Institute.
[180] W. Valentine,et al. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.
[181] M. Koch,et al. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[182] H. Mukhtar,et al. Selenium and Vitamin E for Prostate Cancer: Post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) Status , 2011, Molecular medicine.
[183] Michael I. Jordan,et al. Latent Dirichlet Allocation , 2009 .
[184] A. Mastro,et al. Metastatic breast cancer induces an osteoblast inflammatory response. , 2008, Experimental cell research.
[185] Sung-Hoon Kim,et al. Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density , 2008, International journal of cancer.
[186] J. Schoenman. SMALL, STAND-ALONE, AND STRUGGLING: THE ADOPTION OF HEALTH INFORMATION TECHNOLOGY BY RURAL HOSPITALS , 2007 .
[187] M. Jamaluddin,et al. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. , 2007, Cellular signalling.
[188] S. Legrand-Poels,et al. NF-kappaB activation by reactive oxygen species: fifteen years later. , 2006, Biochemical pharmacology.
[189] Upper Midwest,et al. Pharmacist Staffi ng and the Use of Technology in Small Rural Hospitals: Implications for Medication Safety , 2006 .
[190] L. Coussens,et al. The inflammatory tumor microenvironment and its impact on cancer development. , 2006, Contributions to microbiology.
[191] J. Foidart,et al. Transactivation of MCP‐1/CCL2 by β‐catenin/TCF‐4 in human breast cancer cells , 2006, International journal of cancer.
[192] Raymond B. Runyan,et al. Cell biology of cardiac cushion development. , 2005, International review of cytology.
[193] T. Kishimoto. Interleukin-6: from basic science to medicine--40 years in immunology. , 2005, Annual review of immunology.
[194] Nir Menachemi,et al. Characteristics of hospitals that outsource information system functions. , 2005, Journal of healthcare information management : JHIM.
[195] Delia J. Hernández-Deviez,et al. Functional assay of ARNO and ARF6 in neurite elongation and branching. , 2005, Methods in enzymology.
[196] C. Swanson,et al. Relationships of serum carotenoids, retinol, α-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States) , 2004, Cancer Causes & Control.
[197] A. Mastro,et al. Metastatic breast cancer cells suppress osteoblast adhesion and differentiation , 2004, Clinical & Experimental Metastasis.
[198] L. Mettler,et al. Perioperative levels of interleukin-1beta and interleukin-6 in women with breast cancer. , 2004, Clinical and experimental obstetrics & gynecology.
[199] D. Welch,et al. The skeleton as a unique environment for breast cancer cells , 2004, Clinical & Experimental Metastasis.
[200] M. Wojtukiewicz,et al. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. , 2003, Roczniki Akademii Medycznej w Bialymstoku.
[201] R. Salgado,et al. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. , 2002, Clinical breast cancer.
[202] M. Horowitz,et al. Local Regulators of Bone: IL-1, TNF, Lymphotoxin, Interferon-γ, IL-8, IL-10, IL-4, the LIF/IL-6 Family, and Additional Cytokines , 2002 .
[203] J. Haddad. Nuclear factor (NF)-kappa B blockade attenuates but does not abrogate LPS-mediated interleukin (IL)-1 beta biosynthesis in alveolar epithelial cells. , 2002, Biochemical and biophysical research communications.
[204] G. Combs. Considering the mechanisms of cancer prevention by selenium. , 2001, Advances in experimental medicine and biology.
[205] B. Turnbull,et al. An analysis of cancer prevention by selenium. , 2001, BioFactors.
[206] N. Hynes,et al. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. , 2001, Cancer research.
[207] L. Hefler,et al. Serum cytokine concentrations in patients with cervical cancer: interleukin-4, interferon-gamma, and monocyte chemoattractant protein-1. , 2001, Gynecologic oncology.
[208] I. Fidler,et al. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. , 2001, Neoplasia.
[209] A. Bowie,et al. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. , 2000, Biochemical pharmacology.
[210] Director Brian Baldridge. For More Information , 2000, Journal of the National Cancer Institute.
[211] T. Blundell,et al. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding , 1999, Nature Structural Biology.
[212] T. Hofmann,et al. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. , 1999, Journal of immunology.
[213] L. Oberley,et al. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. , 1998, The Journal of biological chemistry.
[214] L. Packer,et al. Redox regulation of NF-kappa B activation. , 1997, Free radical biology & medicine.
[215] M. J. Earl,et al. The Risks of Outsourcing IT , 1996 .
[216] J. Price,et al. The cell biology of bone growth. , 1994, European journal of clinical nutrition.
[217] G D Roodman,et al. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. , 1992, The Journal of clinical investigation.
[218] A. Ridley,et al. Distinct patterns of actin organization regulated by the small GTP-binding proteins Rac and Rho. , 1992, Cold Spring Harbor symposia on quantitative biology.